Report cover image

North America Point-of-Care Testing (POCT) Market

Publisher Data Bridge Market Research
Published Apr 01, 2025
Length 350 Pages
SKU # DAABD20406740

Description

North America Point-Of-Care Testing (POCT) market size was valued at USD 16.29 billion 2024 and is projected to reach USD 33.68 billion by 2032, with a CAGR of 9.5% during the forecast period of 2025 to 2032.
Market Segmentation:
North America Point-Of-Care-Testing (POCT) Market, By Product Type (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Monitoring Products, Pregnancy and Fertility Testing Products, Hematology Testing Products ,Coagulation Monitoring Products, Drugs-Of-Abuse (DOA) Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Tumor/Cancer Marker Testing Products, Fecal Occult Testing Products, and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Immunoassays, Dipsticks, Molecular Diagnostics, Clinical Chemistry Assays, Microfluidics, Hematology, and Others), Application (Blood Glucose, Infectious Diseases, Vital Sign Monitoring, Cardiac Monitoring, Coagulation, Haematology, Non- Invasive SpO2 Monitoring, Blood Transfusion, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, and Others), Prescription Mode (Prescription-Based Testing and Over The Counter Testing), End User (Hospitals, Home Care, Clinics, Laboratories, Diagnostic Centers, Pathology Labs, Ambulatory Surgery Centers, Elderly Care Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others), Country (U.S., Canada, and Mexico) - Industry Trends & Forecast To 2032

Overview of the North America point-of-care-testing (POCT) market are:

Driver

• Rising Use of POC Testing In Healthcare Facilities
Restraint

• Data Security and Privacy Concerns
Opportunity

• Rising Awareness and Advocacy for Point-Of-Care Testing

Market Players:

The key market players for North America point-of-care-testing (POC) market are listed below:

• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Siemens Healthineers AG
• BD (Becton, Dickinson and Company)
• Abbott (U.S.)
• Pfizer Inc.
• Thermo Fisher Scientific Inc.
• BIOMÉRIEUX
• QIAGEN
• QuidelOrtho Corporation
• Sekisui Diagnostics
• Hologic, Inc.
• Sysmex Corporation
• Meridian Bioscience


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Point-of-care-testing (Poct) Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Multivariate Modelling
2.6 Type Lifeline Curve
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Market End User Coverage Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Healthcare Economy
4.3.1 Healthcare Expenditure
4.3.2 Capex Trends
4.3.3 Capex Allocation
4.3.4 Funding Sources
4.3.5 Industry Benchmarks
4.3.6 Gdp Ratio In Overall Gdp
4.3.7 Healthcare System Structure
4.3.8 Government Policies
4.3.9 Economic Development
4.4 Micro And Macro Economic Factors
4.5 Technology Roadmap: North America Point Of Care Testing
5 North America Point-of-care Testing (Poct) Market: Regulations
6 Market Overview
6.1 Drivers
6.1.1 Rising Use Of Poc Testing In Healthcare Facilities
6.1.2 Rising Incidence Of Substance Abuse
6.1.3 Increased Adoption Of Telemedicine
6.1.4 Advancements Technologies Enhancing Poc Testing With Biosensors And Mobile Integration
6.2 Restraints
6.2.1 Data Security And Privacy Concerns
6.2.2 Lack Of Accuracy And Technical Challenges
6.3 Opportunities
6.3.1 Rising Awareness And Advocacy For Point-of-care Testing
6.3.2 Strategic Initiation And Decision Taken By The Market Players
6.3.3 Expanding Product Range For Point-of-care Testing
6.4 Challenges
6.4.1 Limited Awareness And Acceptance
6.4.2 Impact Of High Maintenance Costs Threaten Point-of-care Testing (Poct) Sustainability In Low-resource Settings
7 North America Point-of-care Testing (Poct) Market, By Product Type
7.1 Overview
7.2 Glucose Monitoring Products
7.2.1 Strips
7.2.2 Meters
7.2.3 Lancets And Lancing Devices
7.3 Infectious Disease Testing Products
7.3.1 Covid-19
7.3.2 Hiv Testing Products
7.3.2.1 Testing Reagents
7.3.2.2 Testing Equipment
7.3.3 Respiratory Infection Testing Products
7.3.4 Sexually Transmitted Diseases (Std) Testing
7.3.4.1 Naat-based Systems
7.3.4.2 Non–naat-based Systems
7.3.5 Hepatitis C Testing Products
7.3.5.1 Hcv Antibody Tests
7.3.5.2 Hcv Viral Load Tests
7.3.6 Influenza Testing Products
7.3.6.1 Traditional Diagnostic Test
7.3.6.1.1 Rapid Influenza Diagnostic Test (Ridt)
7.3.6.1.2 Direct Fluorescent Antibody Test (Dfat)
7.3.6.1.3 Viral Culture
7.3.6.1.4 Serological Assay
7.3.6.2 Molecular Diagnostic Assay
7.3.6.2.1 Rt-pcr
7.3.6.2.2 Loop-mediated Isothermal Amplification-based Assay (Lamp)
7.3.6.2.3 Nucleic Acid Sequence-based Amplification Test (Nasbat)
7.3.6.2.4 Simple Amplification-based Assay (Samba)
7.3.7 Healthcare Associated Infection (Hai) Testing
7.3.8 Tropical Disease Testing Products
7.3.9 Other Infectious Disease Testing Products
7.4 Cardiometabolic Monitoring Products
7.4.1 Cardiac Marker Testing Products
7.4.1.1 Hstnl
7.4.1.2 Bnp
7.4.1.3 D-dimer
7.4.1.4 Ck-mb
7.4.1.5 Myoglobin
7.4.2 Blood Gas/Electrolyte Testing Products
7.4.2.1 Blood Gas/Electrolyte Testing Consumables
7.4.2.1.1 Cartridges
7.4.2.1.2 Reagents
7.4.2.2 Blood Gas/Electrolyte Testing Instruments
7.4.2.2.1 Portable
7.4.2.2.1.1 Combined Analyzers
7.4.2.2.1.2 Blood Gas Analyzers
7.4.2.2.1.3 Electrolyte Analyzers
7.4.2.2.2 Benchtop
7.4.2.2.2.1 Combined Analyzers
7.4.2.2.2.2 Blood Gas Analyzers
7.4.2.2.2.3 Electrolyte Analyzers
7.4.3 Hba1c Testing Products
7.4.3.1 Hba1c Testing Instruments
7.4.3.2 Hba1c Testing Consumables
7.4.4 Poc Analyzer
7.4.5 Ecg Device
7.4.5.1 Resting Ecg Devices
7.4.5.2 Stress Ecg Devices
7.4.5.3 Holter Monitors
7.5 Pregnancy And Fertility Testing Products
7.6 Pregnancy Testing Products And Fertility Testing Products
7.6.1 Strips/ Dip Sticks And Cards
7.6.2 Mid Stream Devices
7.6.3 Cassettes
7.6.4 Digital Devices
7.6.5 Line-indicator Devices
7.6.6 Luteinizing Hormone (Lh) Urine Test
7.6.7 Fsh Test
7.6.8 Others
7.7 Haematology Testing Products
7.8 Coagulation Monitoring Products
7.8.1 Anticoagulation Monitoring Devices
7.8.1.1 Prothrombin Time/International Normalized Ratio (Pt-inr) Testing Devices
7.8.1.2 Activated Clotting Time (Act)
7.8.1.3 Activated Partial Thromboplastin Time (Appt)
7.8.2 Platelet Function Monitoring Devices
7.8.3 Viscoelastic Coagulation Monitoring Devices
7.8.3.1 Rotational Thromboelastometry (Rotem)
7.8.3.2 Thromboelastography (Teg)
7.9 Drug-of-abuse (Doa) Testing Products
7.9.1 Doa Analysers
7.9.1.1 Immunoassays
7.9.1.2 Chromatographic Devices
7.9.1.3 Breath Analysers
7.9.2 Rapid Testing Devices
7.9.2.1 Urine Testing Devices
7.9.2.2 Oral Fluid Testing Devices
7.9.3 Others
7.10 Urinalysis Testing Products
7.10.1 Poc Urine Strip Self-testing
7.10.2 Poc Urine Test Strip Professional Testing
7.11 Cholesterol Testing Products
7.11.1 Testing Kits
7.11.2 Instruments
7.11.2.1 Table-top Analyzers
7.11.2.2 Hand-held Analyzers
7.12 Tumor/Cancer Marker Testing Products
7.13 Fecal Occult Testing Products
7.13.1 Guaiac Fob Stool Test
7.13.2 Lateral Flow Immuno-fob Test
7.13.3 Immuno-fob Agglutination Test
7.13.4 Immuno-fob Elisa Test
7.14 Others
8 North America Point-of-care Testing (Poct) Market, By Prescription Mode
8.1 Overview
8.2 Otc Testing
8.3 Prescription-based Testing
9 North America Point-of-care Testing (Poct) Market, By Platform
9.1 Overview
9.2 Lateral Flow Assays/Immunochromatography Tests
9.3 Immunoassays
9.4 Dipsticks
9.5 Molecular Diagnostics
9.6 Clinical Chemistry Assays
9.7 Microfluidics
9.8 Hematology
9.9 Others
10 North America Point-of-care-testing (Poct) Market, By Application
10.1 Overview
10.2 Blood Glucose
10.3 Infectious Diseases
10.3.1 Covid-19 Testing
10.3.2 Hiv Testing
10.3.3 Hepatitis C Testing
10.3.4 Influenza Testing
10.3.5 Tuberculosis Testing
10.3.6 Others
10.4 Vital Sign Monitoring
10.5 Cardiac Monitoring
10.6 Coagulation
10.7 Haematology
10.8 Non- Invasive Spo2 Monitoring
10.9 Blood Transfusion
10.10 Non- Invasive Pco2 Monitoring
10.11 Whole Blood Analysis
10.12 Others
11 North America Point-of-care Testing (Poct) Market, By End User
11.1 Overview
11.2 Hospitals
11.2.1 Private
11.2.2 Public
11.2.3 Private If Further Sub-segmented Into Tier 1, Tier 2 And Tier 3.
11.2.3.1 Tier 1
11.2.3.2 Tier 2
11.2.3.3 Tier 3
11.3 Home Care
11.4 Clinics
11.5 Laboratories
11.6 Diagnostic Centers
11.7 Pathology Labs
11.8 Ambulatory Surgery Centers
11.9 Elderly Care Centers
11.10 Others
12 North America Point-of-care-testing (Poct) Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.3 Retail Sales
12.4 Online Sales
12.5 Others
13 North America Point-of-care-testing (Poct) Market, By Region
13.1 North America
13.1.1 U.S
13.1.2 Canada
13.1.3 Mexico
14 North America Point-of-care Testing (Poct) Market: Company Landscape
14.1 Company Share Analysis: Global
15 Swot Analysis
16 Company Profiles
16.1 F. Hoffmann-la Roche Ltd
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Development
16.2 Danaher
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Development
16.3 Siemens Healthineers Ag
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Development
16.4 Bd Veritor(Bd)
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Development
16.5 Abbott Point Of Care Inc(Abbott)
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Company Share Analysis
16.5.4 Product Portfolio
16.5.5 Recent Development
16.6 Accubiotech Co., Ltd.
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Development
16.7 Abaxis (Abaxis Is A Part Of Zoetis)
16.7.1 Company Snapshot
16.7.2 Product Portfolio
16.7.3 Recent Development
16.8 Binx Health
16.8.1 Company Snapshot
16.8.2 Solution Portfolio
16.8.3 Recent Development
16.9 Biomerieux
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Development
16.10 Bio- Rad Laboratories, Inc.
16.10.1 Company Snapshot
16.10.2 Product Portfolio
16.10.3 Recent Development
16.11 Chembio Diagnostics, Inc.
16.11.1 Company Snapshot
16.11.2 Product Portfolio
16.11.3 Recent Development
16.12 Ekf Diagnostics Holdings Plc
16.12.1 Company Snapshot
16.12.2 Product Portfolio
16.12.3 Recent Development
16.13 Hologic, Inc
16.13.1 Company Snapshot
16.13.2 Revenue Analysis
16.13.3 Product Portfolio
16.13.4 Recent Development
16.14 Lamdagen Corporation
16.14.1 Company Snapshot
16.14.2 Product Portfolio
16.14.3 Recent Development
16.15 Meridian Bioscience
16.15.1 Company Snapshot
16.15.2 Product Portfolio
16.15.3 Recent Development
16.16 Nova Biomedical
16.16.1 Company Snapshot
16.16.2 Product Portfolio
16.16.3 Recent Development
16.17 Pfizer Inc.
16.17.1 Company Snapshot
16.17.2 Product Portfolio
16.17.3 Recent Development
16.18 Pts Diagnostics
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Development
16.19 Qiagen
16.19.1 Company Snapshot
16.19.2 Revenue Analysis
16.19.3 Product Portfolio
16.19.4 Recent Development
16.20 Quidelortho Corporation
16.20.1 Company Snapshot
16.20.2 Revenue Analysis
16.20.3 Product Portfolio
16.20.4 Recent Development
16.21 Quantumdx Group Ltd.
16.21.1 Company Snapshot
16.21.2 Product Portfolio
16.21.3 Recent Development
16.22 Sekisui Diagnostics
16.22.1 Company Snapshot
16.22.2 Product Portfolio
16.22.3 Recent. Development
16.23 Sienco, Inc.
16.23.1 Company Snapshot
16.23.2 Product Portfolio
16.23.3 Recent Updates
16.24 Sysmex Corporation
16.24.1 Company Snapshot
16.24.2 Revenue Analysis
16.24.3 Product Portfolio
16.24.4 Recent Development
16.25 Trinity Biotech
16.25.1 Company Snapshot
16.25.2 Revenue Analysis
16.25.3 Product Portfolio
16.25.4 Recent Development
16.26 Trividia Health, Inc.
16.26.1 Company Snapshot
16.26.2 Product Portfolio
16.26.3 Recent Updates
16.27 Thermo Fisher Scientific Inc.
16.27.1 Company Snapshot
16.27.2 Revenue Analysis
16.27.3 Product Portfolio
16.27.4 Recent Development
16.28 Werfen
16.28.1 Company Snapshot
16.28.2 Product Portfolio
16.28.3 Recent Development
17 Questionnaire
18 Related Reports
List Of Tables
Table 1 North America Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 2 North America Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 3 North America Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 4 North America Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 5 North America Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 6 North America Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 7 North America Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 8 North America Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 9 North America Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousands)
Table 10 North America Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 11 North America Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 12 North America Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 13 North America Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 14 North America Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 15 North America Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 16 North America Hepatitis C Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousands)
Table 17 North America Hepatitis C Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 18 North America Hepatitis C Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 19 North America Influenza Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 20 North America Traditional Diagnostic Test In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 21 North America Traditional Diagnostic Test In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 22 North America Traditional Diagnostic Test In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 23 North America Molecular Diagnostic Assay In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 24 North America Molecular Diagnostic Assay In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 25 North America Molecular Diagnostic Assay In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 26 North America Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousands Units)
Table 27 North America Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 28 North America Cardiometabolic Monitoring Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 29 North America Cardiometabolic Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 30 North America Cardiac Marker Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 31 North America Cardiac Marker Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 32 North America Cardiac Marker Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 33 North America Blood Gas/Electrolyte Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 34 North America Blood Gas/Electrolyte Testing Consumables In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 35 North America Blood Gas/Electrolyte Testing Consumables In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 36 North America Blood Gas/Electrolyte Testing Consumables In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 37 North America Blood Gas/Electrolyte Testing Instruments In Point-of-care-testing (Poct) Market, By Type, 2018-2032 (Usd Thousand)
Table 38 North America Portable In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 39 North America Portable In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 40 North America Portable In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 41 North America Benchtop In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousands)
Table 42 North America Benchtop In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 43 North America Benchtop In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 44 North America Hba1c Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 45 North America Hba1c Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 46 North America Hba1c Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 47 North America Poc Analyzer In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 48 North America Poc Analyzer In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 49 North America Ecg Device In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 50 North America Ecg Device In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 51 North America Ecg Device In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 52 North America Pregnancy And Fertility Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 53 North America Pregnancy And Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 54 North America Pregnancy Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 55 North America Pregnancy Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousands Units)
Table 56 North America Pregnancy Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 57 North America Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 58 North America Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 59 North America Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 60 North America Haematology Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 61 North America Coagulation Monitoring Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 62 North America Coagulation Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousands)
Table 63 North America Anticoagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 64 North America Anticoagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 65 North America Anticoagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 66 North America Viscoelastic Coagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Method, 2018-2032 (Usd Thousands)
Table 67 North America Drugs-of-abuse (Doa) Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 68 North America Drug-of-abuse (Doa) Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 69 North America Doa Analyzers In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousands)
Table 70 North America Doa Analyzers In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Unit)
Table 71 North America Doa Analyzers Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 72 North America Rapid Testing Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 73 North America Rapid Testing Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 74 North America Rapid Testing Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 75 North America Urinalysis Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 76 North America Urinalysis Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 77 North America Urinalysis Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 78 North America Urinalysis Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 79 North America Cholesterol Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 80 North America Cholesterol Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 81 North America Cholesterol Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousands Units)
Table 82 North America Cholesterol Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 83 North America Instruments In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousands)
Table 84 North America Instruments In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 85 North America Instruments In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 86 North America Tumor/Cancer Marker Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 87 North America Fecal Occult Testing Products In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 88 North America Fecal Occult Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 89 North America Fecal Occult Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousands Units)
Table 90 North America Fecal Occult Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 91 North America Others In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 92 North America Point-of-care-testing (Poct) Market, By Prescription Mode, 2018-2032 (Usd Thousands)
Table 93 North America Otc Testing In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 94 North America Prescription-based Testing In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 95 North America Point-of-care-testing (Poct) Market, By Platform, 2018-2032 (Usd Thousand)
Table 96 North America Lateral Flow Assays/Immunochromatography Tests In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 97 North America Immunoassays In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 98 North America Dipsticks In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 99 North America Molecular Diagnostics In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 100 North America Clinical Chemistry Assays In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 101 North America Microfluidics In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 102 North America Hematology In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 103 North America Others In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 104 North America Point-of-care-testing (Poct) Market, By Application, 2018-2032 (Usd Thousand)
Table 105 North America Blood Glucose In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 106 North America Infectious Diseases In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 107 North America Infectious Diseases In Point-of-care-testing (Poct) Market, By Type, 2018-2032 (Usd Thousand)
Table 108 North America Vital Sign Monitoring In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 109 North America Cardiac Monitoring In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 110 North America Coagulation In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 111 North America Haematology In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 112 North America Non- Invasive Spo2 Monitoring In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 113 North America Blood Transfusion In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 114 North America Non- Invasive Pco2 Monitoring In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 115 North America Whole Blood Analysis In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 116 North America Others In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 117 North America Point-of-care-testing (Poct) Market, By End User, 2018-2032 (Usd Thousand)
Table 118 North America Hospitals In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousands)
Table 119 North America Hospitals In Point-of-care-testing (Poct) Market, By Type, 2018-2032 (Usd Thousands)
Table 120 North America Private In Point-of-care-testing (Poct) Market, By Level, 2018-2032 (Usd Thousands)
Table 121 North America Public In Point-of-care-testing (Poct) Market, By Level, 2018-2032 (Usd Thousands)
Table 122 North America Home Care In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 123 North America Clinics In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 124 North America Laboratories In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 125 North America Diagnostic Centers In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 126 North America Pathology Labs In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 127 North America Ambulatory Surgery Centers In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 128 North America Elderly Care Centers In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 129 North America Others In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Thousand)
Table 130 North America Point-of-care-testing (Poct) Market, By Distribution Channel, 2018-2032 (Usd Million)
Table 131 North America Direct Tender In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Millions)
Table 132 North America Retail Sales In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Millions)
Table 133 North America Online Sales In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Millions)
Table 134 North America Others In Point-of-care-testing (Poct) Market, By Region, 2018-2032 (Usd Millions)
Table 135 North America Point-of-care-testing (Poct) Market, By Country, 2018-2032 (Usd Thousand)
Table 136 North America Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 137 North America Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 138 North America Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 139 North America Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 140 North America Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 141 North America Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 142 North America Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 143 North America Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 144 North America Infectious Disease Testing Products

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us